218 related articles for article (PubMed ID: 8335978)
1. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
3. Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
Sampaio EP; Moreira AL; Sarno EN; Malta AM; Kaplan G
J Exp Med; 1992 Jun; 175(6):1729-37. PubMed ID: 1588290
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
5. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation.
Haslett PA; Roche P; Butlin CR; Macdonald M; Shrestha N; Manandhar R; Lemaster J; Hawksworth R; Shah M; Lubinsky AS; Albert M; Worley J; Kaplan G
J Infect Dis; 2005 Dec; 192(12):2045-53. PubMed ID: 16288366
[TBL] [Abstract][Full Text] [Related]
7. IgG antibody subclasses, tumor necrosis factor and IFN-gamma levels in patients with type II lepra reaction on thalidomide treatment.
Partida-Sanchez S; Favila-Castillo L; Pedraza-Sanchez S; Gomez-Melgar M; Saul A; Estrada-Parra S; Estrada-Garcia I
Int Arch Allergy Immunol; 1998 May; 116(1):60-6. PubMed ID: 9623511
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in erythema nodosum leprosum (ENL).
Bourdillon C
Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
[No Abstract] [Full Text] [Related]
10. [Bullous erythema nodosum leprosum. A case report in French Guiana].
CouppiƩ P; Sainte-Marie D; About V; Heid E; Pradinaud R
Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
[TBL] [Abstract][Full Text] [Related]
11. Our experience of the use of thalidomide in the steroid-dependent severe erythema nodosum leprosum.
Chaudhry NS; Rath SR; Visvanath V; Torsekar RG
Indian J Dermatol Venereol Leprol; 2009; 75(2):189-90. PubMed ID: 19293514
[No Abstract] [Full Text] [Related]
12. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
13. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
Sampaio EP; Malta AM; Sarno EN; Kaplan G
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
[TBL] [Abstract][Full Text] [Related]
14. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
[TBL] [Abstract][Full Text] [Related]
15. Short report: erythema nodosum leprosum lymphadenitis.
Fiallo P; Pesce C; Lenti E; Nunzi E
Am J Trop Med Hyg; 1995 Apr; 52(4):297-8. PubMed ID: 7741163
[TBL] [Abstract][Full Text] [Related]
16. Thalidomide for erythema nodosum leprosum and other applications.
Okafor MC
Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
[TBL] [Abstract][Full Text] [Related]
17. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
18. Thalidomide in erythema nodosum leprosum.
Jew LJ; Middleton RK
DICP; 1990 May; 24(5):482-3. PubMed ID: 2188435
[No Abstract] [Full Text] [Related]
19. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
[TBL] [Abstract][Full Text] [Related]
20. Interventions for erythema nodosum leprosum.
Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]